Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Parkinson Disease Topic Center

Hands holding a head in profile with an illustrated heart over brain
News
Subjective Cognitive Complaints in Parkinson Disease May Signal Future Cognitive Decline
01/08/2024
Jolynn Tumolo
Reported by more than a third of patients with Parkinson disease (PD), subjective cognitive complaints could be a risk marker of subsequent cognitive decline.
Reported by more than a third of patients with Parkinson disease (PD), subjective cognitive complaints could be a risk marker of subsequent cognitive decline.
Reported by more than a third of...
01/08/2024
Neurology
News
Tackle Football May Contribute to Parkinson Disease Risk
12/13/2023
Jolynn Tumolo
Playing tackle football is associated with higher odds of having a diagnosis of parkinsonism or Parkinson disease (PD), suggests a study published in JAMA Network Open.
Playing tackle football is associated with higher odds of having a diagnosis of parkinsonism or Parkinson disease (PD), suggests a study published in JAMA Network Open.
Playing tackle football is...
12/13/2023
Neurology
Which gastrointestinal syndrome didn't increase risk of Parkinson disease diagnosis?
Quiz
Which gastrointestinal syndrome didn't increase risk of Parkinson disease diagnosis?
10/23/2023
Do you remember this study?
Do you remember this study?
Do you remember this study?
10/23/2023
Neurology
Peripheral Auditory Deficits More Likely in Patients With Migraine, Parkinson, Multiple Sclerosis
News
Peripheral Auditory Deficits More Likely in Patients With Migraine, Parkinson, Multiple Sclerosis
09/18/2023
Jolynn Tumolo
The risk of peripheral auditory deficits are higher in patients with migraine/headache disorders, Parkinson disease, and multiple sclerosis than in healthy individuals, according to a systematic review published in Frontiers in Neurology. 
The risk of peripheral auditory deficits are higher in patients with migraine/headache disorders, Parkinson disease, and multiple sclerosis than in healthy individuals, according to a systematic review published in Frontiers in Neurology. 
The risk of peripheral auditory...
09/18/2023
Neurology
Four Gastrointestinal Syndromes May Specifically Predict Parkinson Disease
News
Four Gastrointestinal Syndromes May Specifically Predict Parkinson Disease
09/10/2023
Jolynn Tumolo
Dysphagia, gastroparesis, constipation, and IBS without diarrhea appear to increase the risk of a subsequent diagnosis of idiopathic Parkinson disease, according to a study published online ahead of print in the journal Gut.
Dysphagia, gastroparesis, constipation, and IBS without diarrhea appear to increase the risk of a subsequent diagnosis of idiopathic Parkinson disease, according to a study published online ahead of print in the journal Gut.
Dysphagia, gastroparesis,...
09/10/2023
Neurology
Pencils spell out quiz.
Quiz
How much do childhood nightmares increase Parkinson disease risk?
08/18/2023
Put your neurology knowledge to the test with this quick quiz!
Put your neurology knowledge to the test with this quick quiz!
Put your neurology knowledge to...
08/18/2023
Neurology
Meta-Analysis Finds No Difference in Outcomes With Standard vs Nonstandard PT for PD
News
Meta-Analysis Finds No Difference in Outcomes With Standard vs Nonstandard PT for PD
08/07/2023
Jolynn Tumolo
A systematic review and meta-analysis of physical therapy (PT) in patients with Parkinson disease (PD) found no significant difference between standard PT and nonstandard PT for balance, gait, and motor outcomes. Researchers published their...
A systematic review and meta-analysis of physical therapy (PT) in patients with Parkinson disease (PD) found no significant difference between standard PT and nonstandard PT for balance, gait, and motor outcomes. Researchers published their...
A systematic review and...
08/07/2023
Neurology
Study IDs New Mechanism Behind Benefit of Exercise in Early Parkinson Disease
News
Study IDs New Mechanism Behind Benefit of Exercise in Early Parkinson Disease
07/31/2023
Jolynn Tumolo
According to the study, daily treadmill training reduced the spread of toxic alpha-synuclein aggregates in the animals.
According to the study, daily treadmill training reduced the spread of toxic alpha-synuclein aggregates in the animals.
According to the study, daily...
07/31/2023
Neurology
A child sleeps with their hand tucked under their head
News
Persistent Nightmares in Childhood Linked With Cognitive Impairment, Parkinson Disease Development
07/18/2023
Jolynn Tumolo
Having persistent distressing dreams in middle childhood was associated with an 85% increased risk of developing cognitive impairment or Parkinson disease by age 50 compared with never having distressing dreams.
Having persistent distressing dreams in middle childhood was associated with an 85% increased risk of developing cognitive impairment or Parkinson disease by age 50 compared with never having distressing dreams.
Having persistent distressing...
07/18/2023
Neurology
Parkinson Disease Incidence Linked to Air Pollution in US
News
Parkinson Disease Incidence Linked to Air Pollution in US
06/12/2023
Evi Arthur
Researchers have found an association between Parkinson disease (PD) and air pollution in the United States, with the strongest link in the Rocky Mountain region. Findings were presented at the 2023 American Academy of Neurology annual...
Researchers have found an association between Parkinson disease (PD) and air pollution in the United States, with the strongest link in the Rocky Mountain region. Findings were presented at the 2023 American Academy of Neurology annual...
Researchers have found an...
06/12/2023
Neurology

Advertisement

Advertisement

News

acupuncture
News
Acupuncture Improves Sleep, Quality of Life in Patients With Parkinson Disease
07/08/2024
Sleep scores in patients with Parkinson disease (PD) improved a significant 29.65 points on the Parkinson Disease Sleep Scale after 4 weeks of acupuncture treatment, according to a study published in JAMA Network Open.
Sleep scores in patients with Parkinson disease (PD) improved a significant 29.65 points on the Parkinson Disease Sleep Scale after 4 weeks of acupuncture treatment, according to a study published in JAMA Network Open.
Sleep scores in patients with...
07/08/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
FDA Rejects Parkinson Drug Due to 3rd-Party Manufacturing Concerns
07/02/2024
The US Food and Drug Administration (FDA) rejected AbbVie’s ABBV-95 (foscarbidopa/foslevodopa) last week, raising concerns via complete response letter (CRL) regarding the inspection of a third-party manufacturer listed in the drug...
The US Food and Drug Administration (FDA) rejected AbbVie’s ABBV-95 (foscarbidopa/foslevodopa) last week, raising concerns via complete response letter (CRL) regarding the inspection of a third-party manufacturer listed in the drug...
The US Food and Drug...
07/02/2024
Neurology
Researchers Discover Novel DNA Methylation Patterns in Patients with PD
News
Researchers Discover Novel DNA Methylation Patterns in Patients With PD
05/13/2024
Jolynn Tumolo
Alterations in DNA methylation patterns, discovered in the blood of patients with Parkinson disease (PD), have the potential to serve as an epigenetic biomarker for PD, according to study results published in the Annals of Neurology.
Alterations in DNA methylation patterns, discovered in the blood of patients with Parkinson disease (PD), have the potential to serve as an epigenetic biomarker for PD, according to study results published in the Annals of Neurology.
Alterations in DNA methylation...
05/13/2024
Neurology
Brain with stethoscope and pills
News
Prasinezumab May Benefit Early-Stage Parkinson Patients With Rapid Progression
04/23/2024
Jolynn Tumolo
Prasinezumab may ease motor worsening to a greater extent in patients with more rapidly progressing early-stage Parkinson disease (PD) than in other early-stage PD patients, according to an exploratory analysis.
Prasinezumab may ease motor worsening to a greater extent in patients with more rapidly progressing early-stage Parkinson disease (PD) than in other early-stage PD patients, according to an exploratory analysis.
Prasinezumab may ease motor...
04/23/2024
Neurology
A crop duster plane spreads pesticides on a field
News
Pesticide Exposure Linked Higher Risk of PD in the Rockies and Plains Regions
03/20/2024
Jolynn Tumolo
In the Rocky Mountain and Great Plains region of the United States, pesticide and herbicide use at the county level is associated with increased risk of Parkinson disease (PD) in residents.
In the Rocky Mountain and Great Plains region of the United States, pesticide and herbicide use at the county level is associated with increased risk of Parkinson disease (PD) in residents.
In the Rocky Mountain and Great...
03/20/2024
Neurology
Neurologists examine brain scans
News
Constant Stress Response Causes Cell Death in Neurodegenerative Disease
02/27/2024
Jolynn Tumolo
An unceasing stress response triggered by aggregated proteins may cause the death of brain cells in some neurodegenerative diseases, according to a paper published in the journal Nature.
An unceasing stress response triggered by aggregated proteins may cause the death of brain cells in some neurodegenerative diseases, according to a paper published in the journal Nature.
An unceasing stress response...
02/27/2024
Neurology
News
Dopamine Release Defects Can Occur Before Neurodegeneration in PD
02/16/2024
Jolynn Tumolo
Although the death of dopaminergic neurons and reduced levels of striatal dopamine are often used to explain motor symptoms in patients with Parkinson disease (PD), dopamine deficits may not result from cell death alone, according to a review...
Although the death of dopaminergic neurons and reduced levels of striatal dopamine are often used to explain motor symptoms in patients with Parkinson disease (PD), dopamine deficits may not result from cell death alone, according to a review...
Although the death of...
02/16/2024
Annals of Long-Term Care
News
Long-Term Impact of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life in Parkinson Disease
02/07/2024
Hannah Musick
A recent trial published in JAMA Network Open found that patients with advanced Parkinson disease who received subthalamic nucleus may experience a more stable quality of life due to improved mobility.
A recent trial published in JAMA Network Open found that patients with advanced Parkinson disease who received subthalamic nucleus may experience a more stable quality of life due to improved mobility.
A recent trial published in JAMA...
02/07/2024
Annals of Long-Term Care
neurologist and patient
News
FDA Approves Rechargeable Neurostimulator to Treat Movement Disorders
01/23/2024
Meagan Thistle
The FDA approved a rechargeable neurostimulator that features a sensing-enabled DBS system for personalized treatment of movement disorders such as Parkinson disease, essential tremor, dystonia, and epilepsy.
The FDA approved a rechargeable neurostimulator that features a sensing-enabled DBS system for personalized treatment of movement disorders such as Parkinson disease, essential tremor, dystonia, and epilepsy.
The FDA approved a rechargeable...
01/23/2024
Neurology
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
News
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
01/15/2024
Evi Arthur
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was...
01/15/2024
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement